MEDVi is a telehealth weight loss platform that provides compounded GLP-1 medications — semaglutide and tirzepatide — through licensed providers without requiring insurance. The company launched in 2023 and has grown to serve more than 100,000 patients, generating $401 million in 2025 revenue.
MEDVi holds LegitScript certification and a 4.4 to 4.5 out of 5 rating on Trustpilot based on more than 11,400 reviews. In February 2026, MEDVi received an FDA warning letter for misleading marketing claims about its compounded medications. The company does not produce the compounded drugs it markets.
This review covers what MEDVi is, how it works, what it costs, what real users report, the FDA warning letter, and how it compares to Ro and Hims. By the end, you’ll know whether MEDVi is the right GLP-1 platform for your weight loss goals.
What Is MEDVi?
MEDVi is a telehealth platform that connects patients with licensed providers who prescribe compounded GLP-1 medications for weight loss, available in 49 U.S. states without insurance requirements. The company was founded in 2023 and is headquartered in San Diego, California.
Here’s the thing: MEDVi is not a healthcare provider or a pharmacy. The company functions as a technology and coordination platform. Licensed providers affiliated with OpenLoop Health review patient information and issue prescriptions. Partner compounding pharmacies then prepare and ship the medications.
The company is LegitScript certified — an independent verification requiring ongoing compliance with state and federal laws and transparency standards. LegitScript certification is required by major payment processors and advertising platforms. The company holds this certification while also having received an FDA warning letter in February 2026.
How Does MEDVi Work?
MEDVi operates through a monthly membership model where patients complete an online health intake, receive a provider review, and — if approved — get compounded GLP-1 medication shipped to their door within 48 to 72 hours. No contract is required. Membership can be cancelled at any time.
The process starts with signing up and completing a health questionnaire. Licensed providers affiliated with OpenLoop Health review the intake and determine prescription eligibility. Enrollment and payment do not guarantee a prescription — prescribing decisions are made independently by licensed clinicians after evaluating individual medical history.
Membership includes unlimited access to MEDVi’s patient care team for 24/7 messaging support. Members can ask questions about progress, side effects, or dosage at any time. Monthly provider check-ins are included. Members receive refills on a month-to-month basis.
What Medications Does MEDVi Offer?
MEDVi primarily offers compounded semaglutide and compounded tirzepatide as injections and oral tablets, along with access to branded Wegovy oral pill and Ozempic injection for qualifying patients. Branded tirzepatide (Zepbound) is not available through MEDVi.
Compounded GLP-1s are produced in FDA-regulated facilities but are not FDA-approved for safety, efficacy, or quality. This is different from branded Wegovy or Zepbound, which hold full FDA approval. MEDVi’s website previously misrepresented the company as the compounder of these medications — the source of the February 2026 FDA warning letter.
MEDVi Medication Options:
- Compounded semaglutide — injection and oral tablet
- Compounded tirzepatide — injection and oral tablet
- Wegovy (semaglutide) — FDA-approved branded oral pill
- Ozempic (semaglutide) — FDA-approved injection
How Much Does MEDVi Cost?
MEDVi charges $179 for the first month and $299 per month for ongoing compounded semaglutide refills, with medication included in the membership cost. No separate medication fee applies. No insurance is required or accepted.
Bottom line: MEDVi is one of the more affordable compounded GLP-1 platforms. The $179 first-month rate is a promotional entry price. At $299 per month for ongoing treatment, MEDVi sits below Ro ($349/mo for Wegovy) and above Henry Meds ($197-$297/mo) for compounded semaglutide.
MEDVi Cost Structure:
| Plan | Cost |
|---|---|
| First month (promotional) | $179 |
| Ongoing monthly refills | $299/month |
| Insurance accepted | No |
| Money-back guarantee | 5-month minimum; minus 25% doctor fee |
| Contract required | No (cancel anytime) |
Does MEDVi Accept Insurance?
No. MEDVi does not accept insurance for any of its services or medications. All costs are paid out-of-pocket by the patient. Some patients may be able to submit receipts to their HSA or FSA for potential reimbursement, depending on their plan terms.
The lack of insurance support is the most significant drawback for patients who have commercial health insurance that covers branded GLP-1 medications. A platform like Ro, which offers a dedicated insurance concierge, can reduce medication costs for insured patients to a fraction of what MEDVi charges.
For patients without GLP-1 insurance coverage — which remains the majority of commercially insured patients — MEDVi’s all-inclusive $299/month pricing for compounded semaglutide is genuinely competitive compared to $1,000-$1,400/month for brand-name versions without coverage.
How Does MEDVi Compare to Competitors on Price?
MEDVi is positioned as a mid-range option in the compounded GLP-1 telehealth market, priced at $299/month for compounded semaglutide — below Ro’s $349/month for branded Wegovy but above Henry Meds’ $197-$297/month range.
The key pricing advantage: medication is included in MEDVi’s membership. Platforms like Ro charge a $145/month membership fee plus the cost of medication separately — meaning actual total cost of care is higher. MEDVi’s $299/month all-in pricing simplifies the math for uninsured patients.
GLP-1 Telehealth Pricing Comparison:
| Provider | Monthly Cost | Medication Type | Insurance |
|---|---|---|---|
| MEDVi | $179 (first), $299 (ongoing) | Compounded semaglutide/tirzepatide | No |
| Henry Meds | $197-$297 | Compounded semaglutide | No |
| Hims & Hers | $199+ | Compounded GLP-1s | Limited |
| Ro (Wegovy) | $199-$349 + $145/mo membership | Branded semaglutide (FDA-approved) | Yes (concierge) |
| Brand-name (no insurance) | $1,000-$1,400 | Wegovy/Zepbound (FDA-approved) | Varies |
Does MEDVi Actually Work?
Yes. MEDVi’s medications are based on semaglutide and tirzepatide — compounds with strong clinical evidence for weight loss in their FDA-approved forms, producing 15-21% body weight reduction in major clinical trials. Compounded versions are not FDA-approved, but they use the same active ingredients.
Clinical trial data for the brand-name equivalents: semaglutide (Wegovy) produced an average 15-17% body weight loss over 68 weeks in the STEP trial program published in the New England Journal of Medicine. Tirzepatide (Zepbound) produced 15-21% body weight reduction at the highest doses in the SURMOUNT trial program published in JAMA.
The caveat: these clinical results come from FDA-approved formulations, not compounded versions. Compounded medications are produced in FDA-regulated facilities but are not individually evaluated for safety, efficacy, or quality. MEDVi’s own platform results represent self-reported user data, not controlled clinical trials.
What Results Do MEDVi Users See?
MEDVi user reviews describe reduced appetite, steady weight loss over multiple months, and improved energy levels as the most commonly reported outcomes. The platform holds a 4.4 to 4.5 out of 5 rating on Trustpilot based on more than 11,400 reviews — a strong signal from a large customer base.
Real user reports include Jane S., who lost 18 lbs (8.2 kg) in 3 months while noting her appetite decreased significantly and weekly virtual consultations kept her accountable. Mark T., a rural patient, highlighted that medication arrived at home in 4 days and the physician monitored progress through online check-ins.
ConsumerAffairs shows a more mixed 3.6 out of 5 rating based on approximately 1,600 reviews. The divergence between Trustpilot and ConsumerAffairs is notable. Trustpilot reviews skew toward invited, satisfied customers. ConsumerAffairs captures a broader complaint pattern, particularly around billing and refund processing.
Is the MEDVi Money-Back Guarantee Real?
Yes. MEDVi offers a money-back guarantee for customers who can demonstrate they haven’t lost weight after following the program for at least 5 months, minus a 25% doctor consultation fee. The guarantee applies only to patients who fully adhered to the program.
The 5-month minimum window means the guarantee is a long-term commitment, not a quick trial option. Patients must document adherence to MEDVi’s program requirements to qualify for a refund. The 25% doctor consultation fee deduction reduces the effective refund amount below 100%.
The guarantee represents a meaningful signal of product confidence for a telehealth platform. In a market segment with many short-lived operators, offering a 5-month money-back guarantee adds accountability. Patients should read the specific terms and conditions on MEDVi’s current website before relying on this guarantee.
What Do MEDVi Reviews Say?
MEDVi reviews are predominantly positive on Trustpilot (4.4-4.5/5 across 11,400+ reviews), with customers praising staff helpfulness, fast shipping, smooth platform experience, and genuine provider care during consultations. ConsumerAffairs shows a more mixed 3.6/5 across 1,600 reviews.
In fact, Trustpilot reviewers overwhelmingly describe a great experience with the company’s care team. Common themes: staff are helpful, professional, and attentive. Quick response times and smooth medication delivery processes receive consistent praise. Many reviewers highlight feeling respected and well-supported throughout their weight loss journey.
The New York Times independently verified MEDVi’s financial claims, confirming $401 million in 2025 revenue. This institutional verification adds credibility to the company’s scale. Business Insider published a critical investigation in 2025 about MEDVi’s AI-powered affiliate marketing practices — a concern separate from patient care quality.
What Are the Positive Experiences?
Positive MEDVi reviews consistently highlight the attentiveness of nurses and doctors during consultations, the convenience of home delivery, and meaningful reductions in appetite and cravings within the first weeks of treatment.
One reviewer on Trustpilot described the nurse as taking time to explain everything about weight gain — a level of attentiveness that surprised them. Another called the staff ‘very helpful, supportive and very friendly,’ praising the pharmacy’s cold-pack packaging as professional and thorough.
The ease of the online platform earns consistent 5-star praise. Patients highlight that the entire process — intake, consultation, prescription, and delivery — happens without leaving home. Rural patients specifically value the telehealth model, with one reviewer noting medication arrived in 4 days and all monitoring happened through online check-ins.
What Are the Common Complaints?
The most common MEDVi complaints involve billing and refund processing issues, with some users experiencing difficulty canceling subscriptions or receiving promised refunds. The ConsumerAffairs 3.6/5 rating reflects this complaint pattern more accurately than the invite-heavy Trustpilot score.
One ConsumerAffairs reviewer described starting injections in January, canceling after months, and not seeing the results expected — highlighting that the program requires consistent use over time. Others describe difficulty resolving billing disputes through customer service channels.
The affiliate marketing controversy flagged by Business Insider in 2025 is a separate concern: MEDVi’s growth relied substantially on AI-generated fake doctor profiles promoting the platform on social media. Gallagher acknowledged ‘maybe 30%’ of advertising came through affiliates. The number of active Medvi ad campaigns on Meta fell from 5,000 to 2,800 after Business Insider’s investigation.
Is MEDVi Legit?
MEDVi is a legitimate, LegitScript-certified telehealth platform with verified revenue and a real, active customer base — but it has received an FDA warning letter and has been implicated in deceptive AI-generated marketing practices. It is not a scam, but it requires informed engagement.
And here’s what that means practically: MEDVi cannot get or keep LegitScript certification if it is fraudulently operating. Scam operations cannot hold that certification. The company has $401 million in verified annual revenue. These are not the markers of a fake business.
The legitimate concerns are: the February 2026 FDA warning letter for misbranding (marketing compounded semaglutide as if MEDVi produced it, when a third-party pharmacy does), the AI-generated fake doctor affiliate marketing network, and ongoing compounding pharmacy partner litigation. None of these disqualify MEDVi as a legitimate platform — but they demand patient awareness.
Has MEDVi Had Any Legal Issues?
Yes. MEDVi received an FDA warning letter on February 20, 2026, citing misbranded compounded semaglutide and tirzepatide marketing that falsely implied MEDVi was the compounder of the drugs displayed on its website.
The FDA warning letter cites violations of sections 502(a) and 502(bb) of the Federal Food, Drug, and Cosmetic Act (FDCA) [21 U.S.C. sections 352(a) and 352(bb)]. The violations involve false or misleading claims in the labeling and advertising of compounded drug products — not product safety failures.
Business Insider reported in 2025 that MEDVi’s affiliate marketing included AI-generated fake doctor profiles, one of which dropped the ‘MD’ designation after Business Insider’s inquiry. MEDVi’s operating partner, OpenLoop Health, faced separate unresolved litigation and a confirmed data breach — concerns that affect the broader clinical infrastructure, not MEDVi’s platform directly.
What Are the Side Effects of MEDVi Medications?
MEDVi’s compounded GLP-1 medications carry the same class of side effects as brand-name semaglutide and tirzepatide: nausea, vomiting, diarrhea, constipation, stomach pain, and fatigue, most pronounced during the dose escalation phase.
Compounded medications are not individually FDA-evaluated for safety — so while the active ingredients mirror FDA-approved drugs, the excipients, concentration, and manufacturing quality of compounded versions are not independently verified at the product level. MEDVi states its compounding partners use FDA-regulated facilities and GMP-certified manufacturing.
MEDVi provides side effect management support through its 24/7 messaging service. Members experiencing nausea or dosing issues can message the care team for guidance. One Trustpilot reviewer noted that a nurse proactively reached out to arrange a nausea medication prescription — an example of the attentive support the platform advertises.
Who Should Avoid MEDVi?
MEDVi is not appropriate for patients who have commercial insurance that covers branded GLP-1 medications, as the platform does not accept insurance and provides only compounded versions — not the branded FDA-approved versions insurance typically covers.
Patients in the 1 state where MEDVi is unavailable (it operates in 49 states) should seek alternatives. Patients who want branded tirzepatide (Zepbound) should choose a different platform — MEDVi offers compounded tirzepatide but not the branded Eli Lilly product.
Patients with a history of sensitive billing disputes or who prefer a more regulated, FDA-approved medication pathway should consider Ro or a platform that offers branded GLP-1s with insurance navigation. The FDA warning letter and affiliate marketing controversy are context any prospective patient should weigh before enrolling.
How Does MEDVi Compare to Competitors?
MEDVi positions itself as a mid-range, all-inclusive GLP-1 telehealth platform competing primarily with Henry Meds, Hims & Hers, and Ro on price and access for uninsured patients seeking compounded semaglutide or tirzepatide.
The key differentiators: MEDVi includes medication in the monthly cost (no separate medication fee), offers a 5-month money-back guarantee, and provides 24/7 messaging with a care team. These features set it apart from basic prescription-delivery platforms that offer less ongoing support.
The primary weakness vs Ro: MEDVi does not accept insurance and provides only compounded medications, not FDA-approved branded GLP-1s. For patients with insurance, Ro’s concierge service can deliver branded Wegovy at a lower true cost than MEDVi’s $299/month all-in price.
Is MEDVi Better Than Ro or Hims?
MEDVi is better than Ro for uninsured patients who want compounded semaglutide at a lower all-in monthly cost, and better than Hims & Hers for patients who want a dedicated care team with 24/7 messaging and regular provider check-ins.
Ro is better than MEDVi for patients with commercial insurance who want help securing coverage for branded, FDA-approved GLP-1s like Wegovy or Zepbound. Ro’s insurance concierge can produce significantly lower out-of-pocket medication costs for insured patients — making Ro more cost-effective despite its higher published price.
Hims & Hers competes with MEDVi on compounded semaglutide pricing. MEDVi’s 5-month money-back guarantee and included medication cost (no separate membership fee) give it an edge over Hims & Hers for patients prioritizing cost clarity and refund protection. Both platforms received the same Novo Nordisk low-cost Wegovy partnership offer in April 2025.
Should You Try MEDVi at Eat Proteins?
MEDVi is a real, LegitScript-certified telehealth platform with verified financial scale, mostly positive reviews, and competitive pricing for uninsured patients seeking compounded GLP-1 treatment. The FDA warning letter and affiliate marketing concerns are meaningful context, not disqualifiers.
Our team at Eat Proteins recommends MEDVi for patients without insurance coverage for GLP-1 medications who want an affordable, all-inclusive compounded semaglutide or tirzepatide program with real provider support. The $179 first month and $299 ongoing cost beats the $1,000-plus monthly cost of branded drugs without coverage. The 5-month money-back guarantee reduces the financial risk of a longer commitment.
If you have insurance that covers Wegovy or Zepbound, choose Ro instead — the concierge service will save you more money. If you don’t, MEDVi deserves serious consideration. Read the terms on their guarantee. Review the full consult process before committing. The medications work. The question is which platform serves your specific situation best.